Posted May. 15, 2012 at 6:59 a.m.

Premium Lock Cary-based Cornerstone buys drug firm in $150M deal

Published: 2012-05-15 06:59:10
Updated: 2012-05-15 06:59:10

Drug deal Drug deal Image 1 of 2 · Next Image…

Cornerstone Therapeutics has reached a preliminary agreement to acquire acute-care hospital products company EKR Therapeutics and the rights to two of its drugs in a deal valued at up to $150 million....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders